{"data":{"id":"us-in/ic-27-8-14.3-4","jurisdiction":"us-in","citation":"IC 27-8-14.3-4","heading":"\"Biomarker testing\"","body":"Sec. 4. (a) As used in this chapter, \"biomarker testing\" means the analysis of a patient's tissue, blood, or other biospecimen for the presence of a biomarker.\n(b) The term includes:\n(1) single-analyte tests;\n(2) multiplex panel tests;\n(3) protein expression; and\n(4) whole exome, whole genome, and whole transcriptome sequencing.","path":["TITLE 27. INSURANCE","ARTICLE 8. LIFE, ACCIDENT, AND HEALTH","Chapter 14.3. Coverage for Biomarker Testing"],"source_url":"https://iga.in.gov/ic/2026/Title_27.html#27-8-14.3-4","current_through":"2026","vintage":"2026","retrieved_at":"2026-09-25T05:39:04Z","sha256":"6e3db30ff50ebe5e735f7fd8482f8f7a2c02821d3a030f696e689ed0051aab2f","source_id":"us-in","stale":false,"prev":"us-in/ic-27-8-14.3-3","next":"us-in/ic-27-8-14.3-5"},"notice":"GroundRules: Original legal text. Not legal advice."}